Effect of c-erbB(2) and estrogen receptor status on survival of women with primary breast cancer treated with adjuvant cyclophosphamide/methotrexate/fluorouracil.

Miles, D W

Effect of c-erbB(2) and estrogen receptor status on survival of women with primary breast cancer treated with adjuvant cyclophosphamide/methotrexate/fluorouracil. [electronic resource] - International journal of cancer Aug 1999 - 354-9 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial

0020-7136

10.1002/(sici)1097-0215(19990820)84:4<354::aid-ijc4>3.0.co;2-6 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Breast Neoplasms--mortality
Combined Modality Therapy
Cyclophosphamide--administration & dosage
Female
Fluorouracil--administration & dosage
Follow-Up Studies
Humans
Lymph Node Excision
Lymphatic Metastasis
Mastectomy
Menopause
Methotrexate--administration & dosage
Middle Aged
Predictive Value of Tests
Receptor, ErbB-2--analysis
Receptors, Estrogen--analysis
Regression Analysis
Survival Rate
Time Factors